# DoW Vision, Clinical Trial Award

Source: https://welltoldgrants.com/grants/ht942526vrpcta-dow-vision-clinical-trial-award/  
Official notice: https://www.grants.gov/search-results-detail/362183

> Defense Health Agency Contracting Activity - DHACA is offering grants to any type of organization. It expects to make one award worth $2.6 million in total. Applications close on November 12, 2026.

| Field | Value |
|---|---|
| Opportunity number | HT942526VRPCTA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Open |
| Deadline | November 12, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $2.6 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas. Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details. · Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication. · Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health. https://cdmrp.health.mil/pubs/press/2026/vrppreann

## Questions people ask

### Who can apply for DoW Vision, Clinical Trial Award?

Defense Health Agency Contracting Activity - DHACA accepts applications from any type of organization.

### What is the deadline for DoW Vision, Clinical Trial Award?

Closes November 12, 2026 (12 days left). Confirm the date and time in the official notice on Grants.gov.

### How much funding is available?

About $2.6 million in total for one award.